Items where Subject is "32 BIOMEDICAL AND CLINICAL SCIENCES > 3211 Oncology and carcinogenesis > 321111 Solid tumours"
Up a level |
- Fields of Research (57323)
- 32 BIOMEDICAL AND CLINICAL SCIENCES (3307)
- 3211 Oncology and carcinogenesis (263)
- 321111 Solid tumours (16)
- 3211 Oncology and carcinogenesis (263)
- 32 BIOMEDICAL AND CLINICAL SCIENCES (3307)
A
Aghajani, Marra Jai, Yang, Tao, Schmitz, Ulf, James, Alexander, McCafferty, Charles Eugenio, de Souza, Paul, Niles, Navin, and Roberts, Tara L. (2020) Epithelial-to-mesenchymal transition and its association with PD-L1 and CD8 in thyroid cancer. Endocrine Connections, 9. pp. 1028-1041.
C
Charrez, Bérénice, Qiao, Liang, and Hebbard, Lionel (2016) Hepatocellular carcinoma and non-alcoholic steatohepatitis: the state of play. World Journal of Gastroenterology, 22 (8). pp. 2494-2502.
D
Dewdney, Brittany (2021) Characterising the role of fructose metabolism in hepatocellular carcinoma. PhD thesis, James Cook University.
Dewdney, Brittany, Alanzay, Mohammed, Gillman, Rhys, Walker, Sarah, Wankell, Miriam, Qiao, Liang, George, Jacob, Roberts, Alex, and Hebbard, Lionel (2020) The effects of fructose and metabolic inhibition on hepatocellular carcinoma. Scientific Reports, 10. 16769.
Dewdney, Brittany, Roberts, Alexandra, Qiao, Liang, George, Jacob, and Hebbard, Lionel (2020) A sweet connection? Fructose’s role in hepatocellular carcinoma. Biomolecules, 10 (4). 496.
E
Emran, Abdullah Al, Nsengimana, Jérémie, Punnia-Moorthy, Gaya, Schmitz, Ulf, Gallagher, Stuart J., Newton-Bishop, Julia, Tiffen, Jessamy C., and Hersey, Peter (2020) Study of the female sex survival advantage in melanoma—a focus on x-linked epigenetic regulators and immune responses in two cohorts. Cancers, 12. 2082.
G
Gillman, Rhys (2021) Novel targets and strategies in the treatment of liver and oral pharyngeal cancer. Masters (Research) thesis, James Cook University.
Gillman, Rhys, Lopes Floro, Kylie, Wankell, Miriam, and Hebbard, Lionel (2020) The role of DNA damage and repair in liver cancer. Biochimica et Biophysica Acta Reviews on Cancer, 1875 (1). 188493.
H
Harkus, Uasim, Wankell, Miriam, Palamuthusingam, Pranavan, McFarlane, Craig McFarlane, and Hebbard, Lionel (2022) Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data. Seminars in Cancer Biology, 86 (3). pp. 799-815.
M
Mehrian-Shai, Ruty, Reichardt, Juergen K. V., Harris, Curtis C., and Toren, Amos (2019) The gut-brain axis, paving the way to brain cancer. Trends In Cancer, 5 (4). pp. 200-207.
P
Paw, Ekta, Ong, Chelsea D.W., and Vangaveti, Venkat (2020) Pott's puffy tumour in an immunosuppressed adult: case report and systematic review of literature. Journal Of Surgical Case Reports, 12. rjaa510.
S
Sadeghi, Mehdi, Ranjbar, Bijan, Ganjalikhany, Mohamad Reza, Khan, Faiz M., Schmitz, Ulf, Wolkenhauer, Olaf, and Gupta, Shailendra K. (2016) MicroRNA and transcription factor gene regulatory network analysis reveals key regulatory elements associated with prostate cancer progression. PLoS ONE, 11 (12). e0168760.
W
Walker, Sarah, Wankell, Miriam, White, Rose, Ho, Vikki, Deo, Nikita, Devine, Carol, Dewdney, Brittany, Bhathal, Prithi, Govaere, Olivier, Roskams, Tania, Qiao, Liang, George, Jacob, and Hebbard, Lionel (2019) Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model. PLoS One, 14 (2). e0212860.
Wu, Guang, Wilson, George, George, Jacob, Liddle, Christopher, Hebbard, Lionel, and Liang, Qiao (2017) Overcoming treatment resistance in cancer: current understanding and tactics. Cancer Letters, 387. pp. 69-76.
Z
Zhou, Gang, Da Won Bae, Sarah, Nguyen, Romario, Huo, Xiaoqi, Han, Shuanglin, Zhang, Zhiqiang, Hebbard, Lionel, Duan, Wei, Eslam, Mohammed, Liddle, Christopher, Yuen, Lawrence, Lam, Vincent, Qiao, Liang, and George, Jacob (2021) An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells. Cancer Letters, 501. pp. 124-132.
Zhou, Gang, Latchoumanin, Olivier, Bagdesar, Mary, Hebbard, Lionel, Duan, Wei, Liddle, Christopher, George, Jacob, and Qiao, Liang (2017) Aptamer-based therapeutic approaches to target cancer wtem cells. Theranostics, 7 (16). pp. 3948-3961.